PL1959933T3 - Process for the preparation of lyophilized piperacillin sodium in combination with tazobactam sodium, with improved stability after reconstitution - Google Patents

Process for the preparation of lyophilized piperacillin sodium in combination with tazobactam sodium, with improved stability after reconstitution

Info

Publication number
PL1959933T3
PL1959933T3 PL06830298T PL06830298T PL1959933T3 PL 1959933 T3 PL1959933 T3 PL 1959933T3 PL 06830298 T PL06830298 T PL 06830298T PL 06830298 T PL06830298 T PL 06830298T PL 1959933 T3 PL1959933 T3 PL 1959933T3
Authority
PL
Poland
Prior art keywords
sodium
combination
reconstitution
preparation
improved stability
Prior art date
Application number
PL06830298T
Other languages
Polish (pl)
Inventor
Joan Cabre
Josep Salvador
Pere Lloveras
Irina Kosilek
Norbert Atzl
Jose Diago
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL1959933T3 publication Critical patent/PL1959933T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

An improved process for the production of lyophilized Piperacillin alone or in combination with Tazobactam with improved pH adjustment, by degassing the solution of products to a controlled low carbon dioxide content prior to lyophilization.
PL06830298T 2005-12-05 2006-12-01 Process for the preparation of lyophilized piperacillin sodium in combination with tazobactam sodium, with improved stability after reconstitution PL1959933T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74240805P 2005-12-05 2005-12-05
EP06830298A EP1959933B1 (en) 2005-12-05 2006-12-01 Process for the preparation of lyophilized piperacillin sodium in combination with tazobactam sodium, with improved stability after reconstitution
PCT/EP2006/069232 WO2007065862A1 (en) 2005-12-05 2006-12-01 Process for the perparation of lyophilized piperacilline sodium with improved stability after reconstitution

Publications (1)

Publication Number Publication Date
PL1959933T3 true PL1959933T3 (en) 2011-04-29

Family

ID=37806963

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06830298T PL1959933T3 (en) 2005-12-05 2006-12-01 Process for the preparation of lyophilized piperacillin sodium in combination with tazobactam sodium, with improved stability after reconstitution

Country Status (12)

Country Link
US (1) US20090186865A1 (en)
EP (1) EP1959933B1 (en)
JP (1) JP5004964B2 (en)
CN (1) CN101299995B (en)
AT (1) ATE485043T1 (en)
CA (1) CA2629599C (en)
DE (1) DE602006017732D1 (en)
DK (1) DK1959933T3 (en)
ES (1) ES2354910T3 (en)
PL (1) PL1959933T3 (en)
SI (1) SI1959933T1 (en)
WO (1) WO2007065862A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101269072B (en) * 2008-05-09 2010-06-02 郑飞雄 Pharmaceutical composition containing beta-lactamase restrainer and piperacillin sodium with steady content and preparation method thereof
CN101632677B (en) * 2009-08-26 2013-11-20 海南永田药物研究院有限公司 Suspension powder injection of cefoperazone sodium and tazobactam sodium pharmaceutical composition and new application thereof
JP5852316B2 (en) * 2010-03-30 2016-02-03 富山化学工業株式会社 Method for producing piperacillin-containing suspension
CN102382123A (en) * 2011-03-10 2012-03-21 海南美好西林生物制药有限公司 Preparation method of tazobactam sodium
CN102228460A (en) * 2011-04-12 2011-11-02 宁辉 Antibacterial composition and preparation method
WO2013014544A1 (en) * 2011-07-25 2013-01-31 Vardhman Chemtech Limited Method for preparation of composition of piperacillin sodium and tazobactam sodium
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
DE102012021655B4 (en) 2012-11-03 2023-03-30 Hof Sonderanlagenbau Gmbh Process for freeze-drying a moist product provided with a solvent
CN103054818B (en) * 2013-01-28 2014-03-05 苏州二叶制药有限公司 High-quality high-efficiency freeze drying technology
KR102329764B1 (en) * 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
CN103239454B (en) * 2013-05-06 2014-11-05 齐鲁天和惠世制药有限公司 Production method of piperacillin sodium tazobactam sodium freeze-drying preparation for injection
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103550216B (en) * 2013-10-30 2015-03-11 济南康和医药科技有限公司 Piperacillin sodium and tazobactam sodium pharmaceutical composition and preparation method thereof
CN104083372A (en) * 2014-07-13 2014-10-08 江苏海宏制药有限公司 Method for reducing related substance of piperacillin sodium and tazobactam sodium for injection
CN106714799A (en) * 2014-10-08 2017-05-24 泽井制药株式会社 Method for producing freeze-dried preparation
CN105640959B (en) * 2016-01-23 2017-03-15 阎虎林 Avocin and tazobactam sodium drug composition
DE102017217415B4 (en) * 2017-09-29 2022-11-10 OPTIMA pharma GmbH Process and device for freeze drying
CN112076162A (en) * 2020-08-07 2020-12-15 安徽康正康仁药业有限公司 Piperacillin sodium tazobactam sodium probenecid three-part freeze-dried preparation for injection
CN112409381B (en) * 2020-12-03 2022-03-01 山东安信制药有限公司 Piperacillin sodium and tazobactam sodium co-amorphous substance and preparation method thereof
CN112618486B (en) * 2020-12-24 2023-07-18 浙江昂利康制药股份有限公司 Suspension oil for injection and preparation method thereof
CN113209030B (en) * 2021-04-27 2023-04-25 海南通用康力制药有限公司 Preparation method of piperacillin sodium and tazobactam sodium sterile powder injection
CN113750057A (en) * 2021-10-28 2021-12-07 江苏睿实生物科技有限公司 Preparation method of piperacillin sodium and tazobactam sodium freeze-dried preparation for injection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230095B (en) * 1989-04-27 1991-10-05 Parenta Srl PROCEDURE FOR THE PREPARATION OF STERILE FORMS OF INJECTABLE POWDERS OF ANTIBIOTICS.
US20040017918A1 (en) * 2002-07-24 2004-01-29 Christophe Nicolas Process for point-to-point secured transmission of data and electronic module for implementing the process
US6900184B2 (en) * 2003-04-14 2005-05-31 Wyeth Holdings Corporation Compositions containing pipercillin and tazobactam useful for injection
CA2553038A1 (en) * 2004-01-30 2005-08-18 Wyeth Compositions substantially free of galactomannan containing piperacillin and tazobactam

Also Published As

Publication number Publication date
JP5004964B2 (en) 2012-08-22
DK1959933T3 (en) 2011-02-07
JP2009518355A (en) 2009-05-07
DE602006017732D1 (en) 2010-12-02
EP1959933B1 (en) 2010-10-20
SI1959933T1 (en) 2011-02-28
CN101299995B (en) 2013-04-24
EP1959933A1 (en) 2008-08-27
US20090186865A1 (en) 2009-07-23
CA2629599C (en) 2014-04-01
CN101299995A (en) 2008-11-05
WO2007065862A1 (en) 2007-06-14
CA2629599A1 (en) 2007-06-14
ATE485043T1 (en) 2010-11-15
ES2354910T3 (en) 2011-03-21

Similar Documents

Publication Publication Date Title
SI1959933T1 (en) Process for the preparation of lyophilized piperacillin sodium in combination with tazobactam sodium, with improved stability after reconstitution
UA103364C2 (en) Method for enzymatic production of alcohols with four carbon atoms
GB2497218A (en) Method and system for pacing, ack'ing, timing, and handicapping (path) for simultaneous receipt of documents
NZ598520A (en) Probiotic stabilization
CL2012001336A1 (en) Daptomycin solid pharmaceutical composition prepared by lyophilization of an aqueous solution comprising daptomycin and at least one excipient selected from glycine and a non-reducing sugar with a pH of 6.5-7.5; pharmaceutical product; manufacturing method; use to treat bacterial infections.
NZ616202A (en) Production of soluble protein solutions from soy (“s701”)
AR087531A2 (en) A DRINK CONTAINING GELLAN GELLAN WITH HIGH CONTENT OF ACILO, STABLE BEFORE CALCIUM TO ENHANCE IMPROVED COLLOIDAL STABILITY
MY158663A (en) Fermentation broth formulations
WO2013103268A3 (en) Microorganism able to produce l-amino acid, and method for producing l-amino acid by using same
MX2012009362A (en) Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals, and amino acids.
NZ597844A (en) Preparation of soy protein isolate using calcium chloride extraction (”s703”)
TW200700092A (en) Tigecycline compositions and methods of preparation
MY170602A (en) Process for fractionation of biomass
NZ597891A (en) In situ precipitation of calcium carbonate (caco3) by indigenous microorganisms to improve mechanical properties of a geomaterial
MX2012000150A (en) Biological methods for preparing adipic acid.
MY161866A (en) Cell culture improvements
WO2010111344A3 (en) Methods and microorganisms for production of c4-dicarboxylic acids
MX2010007404A (en) Process for the preparation of asenapine and intermediate products used in said process.
WO2011123154A3 (en) Metabolic evolution of escherchia coli strains that produce organic acids
NZ611788A (en) Astringency in soy protein solutions
BR112012015449A2 (en) calcipotriol monohydrate suspension, calcipotriol monohydrate, process for preparing calcipotriol monohydrate nanocrystals, and, pharmaceutical composition
PL1971678T3 (en) Beer-manufacturing process
MY146596A (en) A tablet having improved stability with at least two actives
WO2010103548A3 (en) Improved method for producing lactic acid and derivative thereof
BR112016009619A2 (en) methods for saccharifying a cellulosic material and for producing a fermentation product from cellulosic material